Vaxcyte share price today

(PCVX)

Vaxcyte share price is $86.53 & ₹7,352.97 as on 21 Dec 2024, 2.30 'hrs' IST

$86.53

▲

0.32

(0.37%)

Market is closed - opens 8 PM, 23 Dec 2024

View live Vaxcyte share price in Dollar and Rupees. Guide to invest in Vaxcyte from India. Also see the sentimental analysis on Indian investors investing in Vaxcyte. Get details on the Indian mutual funds that are investing in Vaxcyte. Get Analyst recommendations and forecasts along with all the Vaxcyte's financials.

Vaxcyte share price movements

Today's Low: $86.42
Today's High: $88.88
$86.53
0.13%
Downside
Day's Volatility :2.77%
Upside
2.64%
52 Weeks Low: $53.83
52 Weeks High: $121.06
$86.53
37.79%
Downside
52 Weeks Volatility :55.53%
Upside
28.52%

Vaxcyte Returns

Period	Vaxcyte Inc	Sector (Health Care)	Index (Russel 2000)
3 Months	-22.82%	-11.1%	0.0%
6 Months	14.19%	-6.0%	0.0%
1 Year	38.87%	2.2%	0.0%
3 Years	274.75%	-0.5%	-20.4%

Vaxcyte Key Statistics

in dollars & INR

Previous Close	$86.21
Open	$86.45
Today's High	$88.88
Today's Low	$86.415
Market Capitalization	$10.7B
Today's Volume	$3.4M
52 Week High	$121.055
52 Week Low	$53.83
Revenue TTM	$0.0
EBITDA	$-599.0M
Earnings Per Share (EPS)	$-4.6
Profit Margin	0.0%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-21.06%

How to invest in Vaxcyte from India?

It is very easy for Indian residents to invest directly in Vaxcyte from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Vaxcyte stock in both Indian Rupees (INR) and US Dollars (USD). Search for Vaxcyte or PCVX on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Vaxcyte or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Vaxcyte shares which would translate to 0.010 fractional shares of Vaxcyte as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India , including recognised companies like Vaxcyte, in just a few clicks!

Returns in Vaxcyte for Indian investors in Rupees

Investment Value

₹1,00,000

Vaxcyte investment value today

Current value as on today

₹1,41,066

Returns

₹41,066

(+41.07%)

Returns from Vaxcyte Stock

₹38,870 (+38.87%)

Dollar Returns

₹2,196 (+2.2%)

Indian investors sentiment towards Vaxcyte

Period: Sep 23, 2024 to Dec 22, 2024. Change in 30 Days versus previous period

Search volume for Vaxcyte on INDmoney from India has grown in the last 30 days as on Dec 23, 2024. 6% more investors are searching Vaxcyte in the last 30 days versus the previous period.

Global Institutional Holdings in Vaxcyte

FMR Inc
12.68%
Vanguard Group Inc
9.18%
HHG PLC
8.76%
BlackRock Inc
7.98%
RA Capital Management, LLC
6.97%
Capital Research Global Investors
3.93%

Analyst Recommendation on Vaxcyte

Buy

93%Buy

6%Hold

0%Sell

Based on 15 Wall street analysts offering stock ratings for Vaxcyte(by analysts ranked 0 to 5 stars)

Based on 15 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Vaxcyte

What analysts predicted

Upside of 75.37%

Current:

$86.53

Target:

$151.75

Insights on Vaxcyte

Price Movement
In the last 3 years, PCVX stock has moved up by 268.2%

Vaxcyte Technicals Summary

Sell

Neutral

Buy

Vaxcyte is currently in a neutral trading position according to technical analysis indicators.

Vaxcyte Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Vaxcyte Inc	-2.27%	14.19%	38.87%	274.75%	309.9%
Regeneron Pharmaceuticals, Inc.	-4.9%	-34.03%	-17.38%	10.57%	87.23%
Biontech Se	-0.04%	30.56%	7.97%	-55.63%	240.6%
Alnylam Pharmaceuticals, Inc.	0.22%	10.11%	28.37%	52.34%	108.41%
Vertex Pharmaceuticals Incorporated	-11.91%	-16.36%	-2.55%	78.68%	80.37%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Vaxcyte Inc	NA	NA	NA	-3.96	-0.21	-0.15	NA	27.47
Regeneron Pharmaceuticals, Inc.	17.51	17.51	1.06	45.07	0.17	0.07	NA	272.04
Biontech Se	160.8	NA	0.04	-3.11	-0.02	-0.01	NA	79.73
Alnylam Pharmaceuticals, Inc.	NA	NA	-0.49	-0.19	-15.01	-0.03	NA	0.25
Vertex Pharmaceuticals Incorporated	32.84	NA	1.17	0.55	-0.03	0.12	NA	60.65

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Vaxcyte Inc	Buy	$10.7B	309.9%	NA	0.0%
Regeneron Pharmaceuticals, Inc.	Buy	$77.8B	87.23%	17.51	33.61%
Biontech Se	Buy	$26.7B	240.6%	160.8	-15.36%
Alnylam Pharmaceuticals, Inc.	Buy	$30.8B	108.41%	NA	-15.86%
Vertex Pharmaceuticals Incorporated	Buy	$102.1B	80.37%	32.84	-4.51%

Vaxcyte Dividend announcements

Vaxcyte Earnings
Vaxcyte’s price-to-earnings ratio stands at None
Read More

About Vaxcyte

sutrovax is a biopharmaceutical company dedicated to the delivery of best-in-class conjugate vaccines and novel complex antigen-based vaccines to prevent serious infectious diseases. sutrovax’s lead product candidate is a pneumococcal conjugate vaccine (pcv) that is designed to prevent invasive pneumococcal disease (ipd) caused by streptococcus pneumoniae. sutrovax’s broad-spectrum pcv is designed to provide expanded protection against circulating strains of pneumococcus and has the potential to replace the current vaccines used in infants and adults. the current mainstay vaccine only covers approximately 40% of the circulating strains causing ipd yet generates $6b in annual sales. sutrovax has generated positive pre-clinical proof-of-concept with its significantly broader-spectrum pcv compared head-to-head to current vaccines using well accepted immunological endpoints. in addition to its lead pcv product candidate, the company also has a promising early-stage pipeline addressing othe

Organization	Vaxcyte
Employees	254
CEO	Mr. Grant E. Pickering M.B.A.
Industry	Health Technology

Management People of Vaxcyte

Name	Title
Mr. Grant E. Pickering M.B.A.	Co-Founder, CEO & Director
Mr. Andrew L. Guggenhime M.B.A.	President & CFO
Mr. James Wassil M.B.A., M.S.	Executive VP & COO
Mr. Mikhail Eydelman J.D.	Senior VP, General Counsel, Chief Compliance Officer & Corporate Secretary
Dr. Ashish Khanna M.B.A., Ph.D.	Co-Founder
Dr. Jeff Fairman Ph.D.	Co-Founder & VP of Research
Ms. Elvia Cowan	Senior VP of Finance & Principal Accounting Officer
Ms. Janet Graesser	Senior Vice President of Corporate Communications & Investor Relations
Ms. Whitney Jones	Chief People Officer
Mr. Paul W. Sauer M.B.A.	Senior Vice President of Process Development & Manufacturing

Important FAQs about investing in Vaxcyte from India :

What is Vaxcyte share price today?

Vaxcyte share price today stands at $86.53, Open: $86.45 ; Previous Close: $86.21 ; High: $88.88 ; Low: $86.42 ; 52 Week High: $121.06 ; 52 Week Low: $53.83. The stock opens at $86.45, after a previous close of $86.21. The stock reached a daily high of $88.88 and a low of $86.42, with a 52-week high of $121.06 and a 52-week low of $53.83.

Can Indians buy Vaxcyte shares?

Yes, Indians can invest in the Vaxcyte (PCVX) from India.

With INDmoney, you can buy Vaxcyte at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Vaxcyte at zero transaction cost.

How can I buy Vaxcyte shares from India?

It is very easy to buy Vaxcyte from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Vaxcyte be purchased?

Yes, you can buy fractional shares of Vaxcyte with INDmoney app.

What are the documents required to start investing in Vaxcyte stocks?

To start investing in Vaxcyte, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.